pharmaphorum
JANUARY 5, 2022
A COVID-19 vaccine that could work against multiple variants of the coronavirus – developed by US biotech Gritstone bio – has generated encouraging immune response data in its first clinical trial. The new vaccine differs from the currently approved shots because it delivers antigens for both the spike protein and other proteins found in SARS-CoV-2.
Fierce Healthcare
JANUARY 5, 2022
Magellan Healthcare, NeuroFlow team up on digital mental health program for members. agliadkovskaya. Wed, 01/05/2022 - 18:58.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 5, 2022
The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status. Teliso-V (telisotuzumab vedotin) is pitching to become the first targeted cancer treatment for people with non-small cell lung cancer (NSCLC) whose tumours overexpress c-Met.
Fierce Healthcare
JANUARY 5, 2022
Vera Whole Health to merge with healthcare navigation company Castlight Health in $370M deal. rtorrence. Wed, 01/05/2022 - 14:55.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
JANUARY 5, 2022
GlaxoSmithKline places shingles vaccine Shingrix is among its top prospects, with peak sales potential of almost $6 billion. Now, Pfizer and BioNTech are joining forces to try to grab a slice of the market. Having already brought their mRNA-based CVID-19 vaccine Comirnaty to market at breakneck speed, Pfizer and BioNTech are hoping to fast-track a vaccine for shingles based on the same technology platform through clinical development, with trials due to start later this year.
Fierce Healthcare
JANUARY 5, 2022
Health tech funding snapshot—Found lands $100M for weight care management; GV's latest healthcare bets. hlandi. Wed, 01/05/2022 - 12:29.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
JANUARY 5, 2022
Industry Voices—An innovation engine for virtual care: 4 lessons from The Clinic by Cleveland Clinic. hlandi. Wed, 01/05/2022 - 11:02.
Pharma Marketing Network
JANUARY 5, 2022
Tune in to this episode of the Pharma Marketing Podcast to hear from our guest, Chris Wasden, Head of Pharma Specialty Solutions & Corporate Strategy at Happify Health and Jennifer Ginest, Digital Marketing Manager of PMN , discuss the current role of Digital Therapeutics in Healthcare and were it is headed.
Fierce Healthcare
JANUARY 5, 2022
Highmark Health, Bosch partner on study that will use AI to identify lung conditions in children. agliadkovskaya. Wed, 01/05/2022 - 14:37.
Pharma Marketing Network
JANUARY 5, 2022
If your New Year’s Resolutions include finally cracking the code to deliver Next Best Actions for every HCP engagement, these experts have some advice. Embedding data-driven practices into your organization requires resilience, persistence, and organization-wide governance and commitment. With large global organizations, how do you move toward one shared vision when the business is scattered around the world?
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
JANUARY 5, 2022
Unions go to court to get OSHA to release permanent COVID-19 protection standard. rking. Wed, 01/05/2022 - 15:05.
Pharma Marketing Network
JANUARY 5, 2022
If your New Year’s Resolutions include finally cracking the code to deliver Next Best Actions for every HCP engagement, these experts have some advice. Embedding data-driven practices into your organization requires resilience, persistence, and organization-wide governance and commitment. With large global organizations, how do you move toward one shared vision when the business is scattered around the world?
Fierce Healthcare
JANUARY 5, 2022
AMA pans CDC's 'confusing' COVID-19 isolation guidance, calls for negative test requirement. dmuoio. Wed, 01/05/2022 - 16:00.
Pharma Marketing Network
JANUARY 5, 2022
Tune in to this episode of the Pharma Marketing Podcast to hear from our guest, Chris Wasden, Head of Pharma Specialty Solutions & Corporate Strategy at Happify Health and Jennifer Ginest, Digital Marketing Manager of PMN , discuss the current role of Digital Therapeutics in Healthcare and were it is headed. The post Ep. 17: A Continuation Into the Role of Digital Therapeutics in Healthcare – Jennifer Ginest and Chris Wasden of Happify Health appeared first on Pharma Marketing Network.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
JANUARY 5, 2022
NorthShore, Edward-Elmhurst's 9-hospital merger creates Illinois' third-largest system. dmuoio. Wed, 01/05/2022 - 11:45.
pharmaphorum
JANUARY 5, 2022
AstraZeneca’s PARP inhibitor Lynparza should not be made available routinely on the NHS n England and Wales as a treatment for prostate cancer, according to cost effectiveness agency NICE. That is the conclusion of draft guidance which says that the evidence for Lynparza (olaparib) as a treatment for prostate cancer is uncertain, and therefore not a good use of NHS funds.
Pharma Times
JANUARY 5, 2022
The test is a technological first in determining the metastatic status of a cancer without using prior insight of the primary cancer presented.
Med Ed 101
JANUARY 5, 2022
Before I get to the BCGP 2022 Exam info, we’ve got some big news to share from the Board of Pharmacy Specialties (BPS). If you are looking to take any exam this spring (BCGP, BCPS, BCACP, BCPP, etc.) the registration window is now open as of January 4th, 2022! Alright, now here’s more info on […]. The post BCGP 2022 Exam + Some BIG NEWS On Board Certification appeared first on Med Ed 101.
Druggist
JANUARY 5, 2022
The post PublishPress appeared first on Drug Review & Medical Information You Can Rely On.
Pharma Times
JANUARY 5, 2022
Pressure on care and NHS staff mounts with the spread of the latest Omicron variant of COVID-19.
Expert insights. Personalized for you.
121 
Let's personalize your content